Noninvasive Apoptosis Detection by F-18-Ml10 Micropet/Ct Imaging for Early Monitoring Cancer Anti-Angiogenic Therapy Response

Ming-Wei Wang,Xiao Bao,Ying-Jian Zhang
2015-01-01
Journal of Nuclear Medicine
Abstract:1217 Objectives We aimed to investigate the noninvasive apoptosis detection by 18F-ML10 MicroPET/CT imaging for early monitoring cancer anti-angiogenic therapy (AAT) response using an in vivo molecular imaging strategy since apoptosis plays close relationship to cancer therapy. Methods U87MG tumor models were implanted in female nude mice and separated randomly into treatment and control groups. The treatment groups were intragastrically treated with Sunitinib at the dose level of 80 mg/kg for 7 consecutive days and the control ones with vehicle only. 18F-ML10 MicroPET/CT imaging were scanned at day 0, 1, 3, 7 and 13 after AAT. The tumor uptake i.e.%ID/gmax and the uptake ratios of tumor to muscle (T/M) were measured for the quantitative analysis. The tumor samples were collected and sliced for the immunohistochemical staining and analysis of TUNEL and CD31. Quantitative data were expressed as mean ± SD and analyzed using One-Way ANOVA test and Pearson correlation analysis. Results The noninvasive apoptosis detection during anti-angiogenic therapy was accomplished by longitudinal 18F-ML10 MicroPET/CT imaging. The tumor uptake of 18F-ML10 in the Sunitinib group increased significantly at day 3 post AAT (P Conclusions Noninvasive apoptosis detection during AAT was successfully fulfilled by 18F-ML10 MicroPET/CT imaging, which would be a great potential in vivo molecular imaging strategy for early monitoring response to AAT. Research Support This study was partly supported by National Natural Science Foundation of China (No. 11275050, No. 30700188).
What problem does this paper attempt to address?